Filing Details
- Accession Number:
- 0001562180-19-001504
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-03-01 16:00:29
- Reporting Period:
- 2019-03-01
- Accepted Time:
- 2019-03-01 16:00:29
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
949870 | Boston Beer Co Inc | SAM | Malt Beverages (2082) | 043284048 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1318320 | A David Burwick | C/O The Boston Beer Company, Inc. One Design Center Place, Suite 850 Boston MA 02210 | President And Ceo | No | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Class A Common | Acquisiton | 2019-03-01 | 5,000 | $29.33 | 70,128 | No | 4 | M | Direct | |
Class A Common | Disposition | 2019-03-01 | 2,842 | $310.00 | 67,286 | No | 4 | S | Direct | |
Class A Common | Disposition | 2019-03-01 | 700 | $312.31 | 66,586 | No | 4 | S | Direct | |
Class A Common | Disposition | 2019-03-01 | 1,058 | $313.79 | 65,528 | No | 4 | S | Direct | |
Class A Common | Disposition | 2019-03-01 | 400 | $314.68 | 65,128 | No | 4 | S | Direct | |
Class A Common | Acquisiton | 2019-03-01 | 3,199 | $0.00 | 68,327 | No | 4 | A | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | A | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Class A Common | Stock Option (Right to Buy) | Disposition | 2019-03-01 | 5,000 | $0.00 | 5,000 | $29.33 |
Class A Common | Performance-Based Stock Option (Right to Buy) | Acquisiton | 2019-03-01 | 7,352 | $0.00 | 7,352 | $312.56 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2009-06-02 | 2019-06-01 | No | 4 | M | Direct |
7,352 | 2021-03-01 | 2029-02-28 | No | 4 | A | Direct |
Footnotes
- The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 13, 2018.
- The price shown is the weighted average sale price for the transactions reported on this line. The range of sale prices for the 700 shares is from $312.28 to $312.50. The Filing Person will provide full information regarding the number of shares sold at each separate price upon request of the SEC, the Registrant, or a shareholder of the Registrant.
- The price shown is the weighted average sale price for the transactions reported on this line. The range of sale prices for the 1,058 shares is from $313.52 to $314.35. The Filing Person will provide full information regarding the number of shares sold at each separate price upon request of the SEC, the Registrant, or a shareholder of the Registrant.
- The price shown is the weighted average sale price for the transactions reported on this line. The range of sale prices for the 400 shares is from $314.61 to $314.70. The Filing Person will provide full information regarding the number of shares sold at each separate price upon request of the SEC, the Registrant, or a shareholder of the Registrant.
- Represents a grant of Restricted Stock Units ("RSU's") under the Issuer's Restated Employee Equity Incentive Plan ("EEIP"). RSU's generally vest in four equal installments over a four year period, provided that the Reporting Person remains employed by the Issuer as of the applicable vesting date.
- The shares reported include 66,652 shares of restricted stock subject to vesting conditions.
- The Performance-Based Stock Options were granted pursuant to the Issuer's EEIP. The extent to which the options may become exercisable will be dependent upon the Company achieving certain compounded annual growth rate targets based on net revenue growth in Fiscal Year 2020 over Fiscal Year 2018. The determination of the eligibility for vesting of these options will be made by the Compensation Committee before March 1, 2021.